IQ4I Research & Consultancy Published a New Report on "Contract Drug Discovery Research Outsourcing (CDDRO) Global Market Forecast To- 2018"

Contract Drug Discovery Research Outsourcing (CDDRO) Global Market - Forecast To 2018 analyzes and studies the major competition, market drivers & Opportunities, Restraints & Threats in North America, Europe, Asia-Pacific and Rest of the World, spread through 168 slide. End Quote

(1888PressRelease) February 03, 2015 - Report gives comprehensive insights on the global drug discovery outsourcing market. The report covers all segments, global trends and emerging strategies of the outsourcing market related to drug discovery and preclinical development.

Major contract Drug Discovery Research Outsourcing (CDDRO) players included in the report are Evotec, Charles River Laboratories (CRL), Pharmaceutical Product Development (PPD), Wuxi Apptec, Chem Partner, Syngene, Aurigene, Jubilant, Advinus, GVK Biosciences, TCG Lifesciences and AMRI.

This report caters the need of Contract research organizations, Pharmaceutical /Biotech companies, Academic institutes, Individual researchers, Investors, Service providers and other associated stake holders to identify and analyze the potential of the CDDRO market. The report also provide insights on customer base, number of deals between CRO's and Pharmaceutical /biotech firms, global FTE rates, employee strength & number of companies, FTE revenues of major players, therapeutic area gap analysis and Successful research collaboration outcomes of selected CRO's and Sponsors, which are likely to have an impact on the CDDRO market in the foreseeable future.

This report covers in-depth analysis of major players by therapeutic area of focus, capabilities, geographic presence, business models, financials, collaborations, acquisitions, various marketing strategies adopted along with insightful analysis on conferences, clusters and match making websites.

Some of the key sections covered in the report are given below:

Market Analysis
In the market analysis section, global drug discovery outsourcing market was indicated region wise. The various drug discovery segments and their market shares were estimated. This section also includes the market sizing of new chemical entities and Biologics and their CAGRs. The emerging trends and strategies adopted by global pharmaceutical/biotech companies and their impact on outsourcing market were discussed. In house pipeline of some of the CRO's along with their TA focus, Target, mechanism of action and stage indicated.

- In depth assessment of all segments and sub segments of Global Drug Discovery Outsourcing (CDDRO) market
- Regional analysis of drug discovery outsourcing market
- Market sizing based on molecule type (NCE's and biologics)
- Emerging trends and strategies with KOL opinions
- In house pipeline of some of the CRO's. Therapeutic area, Target, Mechanism of action and Development stage
CRO Business.

The CRO business section provides a deep insight on the various business models adopted by the CDDRO players to achieve better collaboration strategies with the global pharmaceutical/biotech companies. The changing CRO business models were discussed, which indicates the changing landscape and business interest of the CRO industry along with the recent developments of the key players. This section also offers information on key drug discovery and development performance indicators. The global pharmaceutical/Biotech companies R&D expenditure and R&D intensity and the therapeutic area of focus of top 50 pharmaceuticals with respect to R&D expenses were also carried out.

- Discussed various business models adopted by outsourcing companies to collaborate with global pharmaceutical/biotech partners
- Changing CRO business models with recent examples, CRO Business evolutions, certifications
- Key performance indicators /matrix of discovery and development
- Global Pharmaceuticals/Biotech key players R&D expenditure
- Global Pharmaceuticals/Biotech key players R&D intensity
- Top 50 pharmaceuticals (R&D expenses) therapeutic area analysis.

Competitor Analysis
In this section, competitive analysis of key CRO's was performed to analyze their Therapeutic area of focus where they are actively collaborating with global pharmaceuticals/biotech partners. FTE revenue analysis was carried out based on discovery segment revenue and employee strength. This section also includes the estimated customer base of CDDRO key players. An analysis was also done to track the number of deals and acquisitions made by these CDDRO key players. A gap analysis was done to identify the therapeutic areas where the CRO's are lacking expertise and probably could expand
- Global CDDRO key players TA Matrix
- Global snapshot of CDDRO FTE rates by business segments (Chemistry and Biology)
- Region wise CDDRO market Vs No of companies
- Region wise CDDRO market Vs FTE revenues & No of employees
- Global CDDRO Key players FTE revenue analysis
- Global CDDRO Key players customer base analysis
- Global CDDRO Key players deals analysis (collaborations & Acquisitions)
- Global CDDRO Key players Therapeutic Area analysis
- Therapeutic area gap analysis
- Major outcomes of successful research collaboration of Selected CRO's with Major pharmaceutical/Biotech, with key details including (Compound structure, Target & Mechanism, Efficacy values, Publications- Patents/Journals).

Key Players Analysis
The key player's analysis was performed to identify their services & capabilities, TA focus, business models and region wise business operations. The financial chart for each player along with their drug discovery segment revenue and employee strength was provided after excluding manufacturing and clinical operations. In detail analysis of the collaborations of the key players along with their financial details performed.

- Global Key players overview
- Global Key players services & capabilities
- Global Key players therapeutic area of focus
- Global Key players business models
- Global Key players financials
- Global Key players collaborations.

Marketing strategies Analysis
The marketing strategies section covers the various approaches outsourcing companies follow in order to get more visibility in the market and in turn to increase their sales and achieve competitive advantage over their peers. Conference analysis of key outsourcing players was performed for the years 2013 & 2014 to identify top conferences and top players. This section also covers the major drug discovery conferences that are going to take place globally in 2015. Global Pharmaceutical/biotech clusters (region wise) were mapped and the selected lists of clusters are highlighted.

A list of match making websites were covered which offers a platform to promote contract research capabilities. The other marketing strategies such as virtual pharmaceuticals, online RFP's and networking companies are also covered to help the small and midsized CRO's to promote their business.

As websites play an important role in promoting the business, we performed an analysis to identify the companies who are not maximizing the benefit of their internet presence and those who are taking advantage by having an attractive website and effective search engine optimization. This section also includes global website ranking of key players to know the company's website performance. In addition to this, number of LinkedIn followers of key players and key word search volume by company names were also performed.

- Major conferences attended by key players during 2013 & 2014
- Analysis to identify top conferences based on key players attendance
- Analysis to identify top players based on number of conferences attended
- Benefits of partnering with Match Making websites, Virtual pharmaceuticals, Online RFP & networking websites
- Global Pharmaceutical/Biotech Cluster map
- Other marketing strategies analysis (Company website rankings, LinkedIn followers & key word search volume).

###

space

Other Related Press Releases